Differential response of the human renal proximal tubular epithelial cell line HK-2 to shiga toxin types 1 and 2

Infection and Immunity

Volumn 79, Issue 9, 2011, Pages 3527-3540

  Lentz, Erin K ^a   Leyva Illades, Dinorah ^a   Lee, Moo Seung ^a   Cherla, Rama P ^a   Tesh, Vernon L ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROCASPASE 3; VEROTOXIN 1; VEROTOXIN 2;

ARTICLE; CELL MIGRATION; CELL POPULATION; CONTROLLED STUDY; CYTOTOXICITY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; KIDNEY CELL; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; LYSOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHIGELLA DYSENTERIAE; UPREGULATION; VERO CELL;

ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; APOPTOSIS; CASPASE 3; CELL LINE; CERCOPITHECUS AETHIOPS; CHEMOKINE CCL3; CHEMOKINE CCL4; ENDOPLASMIC RETICULUM; ESCHERICHIA COLI; HUMANS; KIDNEY TUBULES, PROXIMAL; LYSOSOMES; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN SYNTHESIS INHIBITORS; SHIGA TOXIN 1; SHIGA TOXIN 2; SHIGELLA DYSENTERIAE; VERO CELLS;

EID: 80052323148     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05139-11     Document Type: Article

References (56)

1. Bauwens, A., et al. 2011. Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells. Thromb. Haemost. 105:515-528.
2. Bernales, S., F. R. Papa, and P. Walter. 2006. Intracellular signaling by the unfolded protein response. Annu. Rev. Cell Dev. Biol. 22:487-508.
3. Boerlin, P., et al. 1999. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J. Clin. Microbiol. 37:497-503.
4. Breckenridge, D. G., M. Germain, J. P. Mathai, M. Nguyen, and G. C. Shore. 2003. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 22:8608-8618.
5. Brigotti, M., et al. 2008. Interactions between Shiga toxins and human polymorphonuclear leukocytes. J. Leukoc. Biol. 84:1019-1027.
6. Chaisri, U., et al. 2001. Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome. Microb. Pathog. 31:59-67.
7. Cherla, R. P., S.-Y. Lee, P. L. Mees, and V. L. Tesh. 2006. Shiga toxin 1-induced cytokine production is mediated by MAP kinase pathways and translation initiation factor eIF4E in the macrophage-like THP-1 cell line. J. Leukoc. Biol. 79:397-407.
8. Cho, B. B., and L. H. Toledo-Pereyra. 2008. Caspase-independent programmed cell death following ischemic stroke. J. Invest. Surg. 21:141-147.
9. DeGrandis, S., H. Law, J. Brunton, C. Gyles, and C. A. Lingwood. 1989. Globotetraosylceramide is recognized by the pig edema disease toxin. J. Biol. Chem. 264:12520-12525.
10. Ellgaard, L., and A. Helenius. 2001. ER quality control: towards an understanding at the molecular level. Curr. Opin. Cell Biol. 13:431-437.
11. Falguières, T., et al. 2001. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol. Biol. Cell 12:2453-2468.
12. Fujii, J., et al. 2003. Rapid apoptosis induced by Shiga toxin in HeLa cells. Infect. Immun. 71:2724-2735.
13. Garibal, J., E. Hollville, B. Renouf, C. Tétaud, and J. Wiels. 2010. Caspase-8-mediated cleavage of Bid and protein phosphatase 2A-mediated activation of Bax are necessary for Verotoxin-1-induced apoptosis in Burkitt's lymphoma cells. Cell Signal. 22:467-475.
14. Haicheur, N., et al. 2000. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. J. Immunol. 165:3301-3308.
15. Haicheur, N., et al. 2000. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. J. Immunol. 165:3301-3308.
16. Harrison, L. M., W. C. E. van Haaften, and V. L. Tesh. 2004. Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1. Infect. Immun. 72:2618-2627.
17. Hughes, A. K., P. K. Stricklett, and D. E. Kohan. 1998. Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells. Kidney Int. 54:426-437.
18. Hughes, A. K., P. K. Stricklett, and D. E. Kohan. 1998. Shiga toxin-1 regulation of cytokine production by human proximal tubule cells. Kidney Int. 54:1093-1106.
19. Inagi, R. 2009. Endoplasmic reticulum stress in the kidney as a novel mediator of kidney injury. Nephron Exp. Nephrol. 112:e1-e9.
20. Inagi, R., et al. 2005. Involvement of endoplasmic reticulum (ER) stress in podocyte injury induced by excessive protein accumulation. Kidney Int. 68: 2639-2650.
21. Jackson, M. P., R. J. Neill, A. D. O'Brien, R. K. Holmes, and J. W. Newland. 1987. Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933. FEMS Microbiol. Lett. 44:109-114.
22. Johannes, L., and W. Römer. 2010. Shiga toxins-from cell biology to biomedical applications. Nat. Rev. Microbiol. 8:105-116.
23. Karpman, D., et al. 1998. Apoptosis of renal cortical cells in the hemolyticuremic syndrome: in vivo and in vitro studies. Infect. Immun. 66:636-644.
24. Kawano, K., M. Okada, T. Haga, K. Maeda, and Y. Goto. 2008. Relationship between pathogenicity for humans and stx genotype in Shiga toxin-producing Escherichia coli serotype O157. Eur. J. Clin. Microbiol. Infect. Dis. 27:227-232.
25. Keepers, T. R., L. K. Gross, and T. G. Obrig. 2007. Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome. Infect. Immun. 75:1229-1236.
26. Kiyokawa, N., et al. 1998. Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2. J. Infect. Dis. 178:178-184.
27. Kodama, T., et al. 1999. Induction of apoptosis in human renal proximal tubular epithelial cells by Escherichia coli verocytotoxin 1 in vitro. Med. Microbiol. Immunol. 188:73-78.
28. Koster, F. T., V. Boonpucknavig, S. Sujaho, R. H. Gilman, and M. M. Rahaman. 1984. Renal histopathology in the hemolytic-uremic syndrome following shigellosis. Clin. Nephrol. 21:126-133.
29. Lee, M.-S., R. P. Cherla, D. Leyva-Illades, and V. L. Tesh. 2009. Bcl-2 regulates the onset of Shiga toxin 1-induced apoptosis in THP-1 cells. Infect. Immun. 77:5233-5244.
30. Lee, S.-Y., R. P. Cherla, I. Caliskan, and V. L. Tesh. 2005. Shiga toxin 1 induces apoptosis in the human myelogenous leukemia cell line THP-1 by a caspase-8-dependent, tumor necrosis factor receptor-independent mechanism. Infect. Immun. 73:5115-5126.
31. Lee, S.-Y., M.-S. Lee, R. P. Cherla, and V. L. Tesh. 2008. Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells. Cell Microbiol. 10:770-780.
32. Lingwood, C. A. 1994. Verotoxin-binding in human renal sections. Nephron 66:21-28.
33. Lord, J. M., L. M. Roberts, and W. I. Lencer. 2005. Entry of protein toxins into mammalian cells by crossing the endoplasmic reticulum membrane: co-opting basic mechanisms of endoplasmic reticulum-associated degradation. Curr. Top. Microbiol. Immunol. 300:149-168.
34. Murata, K., et al. 2006. Verotoxin-1 stimulation of macrophage-like THP-1 cells up-regulates tissue factor expression through activation of c-Yes tyrosine kinase: possible signal transduction in tissue factor up-regulation. Biochim. Biophys. Acta 1762:835-843.
35. Nestoridi, E., R. I. Kushak, D. Duguerre, E. F. Grabowski, and J. R. Ingelfinger. 2005. Up-regulation of tissue factor activity on human proximal tubular epithelial cells in response to Shiga toxin. Kidney Int. 67:2254-2266.
36. Obrig, T. G., T. P. Moran, and J. E. Brown. 1987. The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis. Biochem. J. 244:287-294.
37. Orth, D., et al. 2007. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. Diagn. Microbiol. Infect. Dis. 59:235-242.
38. Proulx, F., E. G. Seidman, and D. Karpman. 2001. Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr. Res. 50:163-171.
39. Rao, R. V., H. M. Ellerby, and D. E. Bredesen. 2004. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ. 11:372-380.
40. Richardson, S. E., M. A. Karmali, L. E. Becker, and C. R. Smith. 1988. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum. Pathol. 19:1102-1108.
41. Rutkowski, D. T., and R. J. Kaufman. 2004. A trip to the ER: coping with stress. Trends Cell Biol. 14:20-28.
42. Ryan, M. J., et al. 1994. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int. 45:48-57.
43. Sandvig, K. 2001. Shiga toxins. Toxicon 39:1629-1635.
44. Sandvig, K., and B. van Deurs. 2002. Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin. FEBS Lett. 529:49-53.
45. Smith, W. E., et al. 2003. Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells. Infect. Immun. 71:1497-1504.
46. Strockbine, N. A., M. P. Jackson, L. M. Sung, R. K. Holmes, and A. D. O'Brien. 1988. Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. J. Bacteriol. 170:1116-1122.
47. Strockbine, N. A., et al. 1986. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect. Immun. 53:135-140.
48. Takeda, T., et al. 1993. Impairment by verotoxin of tubular function contributes to the renal damage seen in haemolytic uraemic syndrome. J. Infect. 27:339-341.
49. Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073-1086.
50. Tesh, V. L. 2010. Induction of apoptosis by Shiga toxins. Future Microbiol. 5:431-453.
51. Tesh, V. L., et al. 1993. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect. Immun. 61:3392-3402.
52. Tesh, V. L., J. E. Samuel, J. A. Burris, J. W. Owens, F. B. J. Taylor, Jr., and R. L. Siegler. 1994. Quantitation and localization of shiga toxin/shiga-like toxin-binding glycolipid receptors in human and baboon tissues, p. 189-192. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier, Amsterdam, The Netherlands.
53. Tewari, M., et al. 1995. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADPribose) polymerase. Cell 81:801-809.
54. Uchida, H., N. Kiyokawa, H. Horie, J. Fujimoto, and T. Takeda. 1999. The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome. Pediatr. Res. 45:133-137.
55. Vittar, N. B., J. Awruch, K. Azizuddin, and V. Rivarola. 2010. Caspaseindependent apoptosis, in human MCF-7c3 breast cancer cells, following photodynamic therapy, with a novel water-soluble phthalocyanine. Int. J. Biochem. Cell Biol. 42:1123-1131.
56. Wilson, C., G. H. Foster, and M. Bitzan. 2005. Silencing of Bak ameliorates apoptosis of human proximal tubular epithelial cells by Escherichia coliderived Shiga toxin 2. Infection 33:362-367.